PubPeer
The online Journal club
login
create account
Home
Publications
Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial
bioRxiv (2021) -
Comments
doi: 10.1101/2021.07.26.21261119
Devang Parikh, Alok Chaturvedi, Naman Shah, Piyush Patel, Ronak Patel, Suma Ray
Go to article
Go to preprint
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})